I'm kicking myself I did take the opportunity to buy a shed load...

I'm kicking myself I did take the opportunity to buy a shed load more at 60c...

It wouldn't necessarily be the end of the company. Depending on the reason for being knocked back they could potentially refile for the same drug again after more testing or targeting it at a more specific market, or give up on it and move on to controlled release moxduo. The problem with that obviously is that they are going to need cash to do that and given the share price will drop to maybe 20c the diltion would be massive.

There is also the potential they could abandon the US and attempt to fastrack approval in other markets in order to get some cash flow going and minimise dilution. The non us market for moxduo should still be sizable but in terms of speed of rollout to a large market the US is unbeatable which is one of the reasons its the main focus for approval.